<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="83575">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02017301</url>
  </required_header>
  <id_info>
    <org_study_id>GAS-800-12-13-1</org_study_id>
    <nct_id>NCT02017301</nct_id>
  </id_info>
  <brief_title>Vector Analysis of Body Composition in Hospitalized Cirrhotic Patients</brief_title>
  <official_title>Influence of Acute Decompensation on Body Composition Determined by Bioelectrical Impedance Vector Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with acute decompensation of cirrhosis, or acute on chronic liver failure often
      present with malnutrition, and due to the in-hospital stay, their nutritional intake can
      vary widely, with several periods of fasting, and sometimes insufficient nutritional
      support. Therefore patients are prone to develop malnutrition or, the already present
      malnutrition worsens its status.

      Our aim is to evaluate the daily changes in nutritional status in patients with acute
      decompensation of cirrhosis and evaluate the changes in plasma and serum biomarkers.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in nutritional status</measure>
    <time_frame>Daily measurement up to 30 days</time_frame>
    <description>Nutritional status will be measured with bioelectrical impedance analysis (Vector and phase angle)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of inflammatory cytokines</measure>
    <time_frame>Samples will be collected at the baseline evaluation.</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">79</enrollment>
  <condition>Infection</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional assessment</intervention_name>
    <description>Daily nutritional assessment with bioelectrical impedance vector analysis, phase angle and mid-arm muscle circumference</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and plasma samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort of hospitalized cirrhotic patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-75 years old

          -  Patients with confirmed cirrhosis.

          -  Any etiology

          -  Hospitalized with acute decompensation of cirrhosis

          -  Signed informed consent

        Exclusion Criteria:

          -  Pregnancy

          -  Amputation

          -  Incomplete data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aldo Torre Delgadillo, M.D. M.Sc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Astrid Ruiz-Margáin, M.Sc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubiran</name>
      <address>
        <city>Mexico</city>
        <state>D.F</state>
        <zip>14080</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 6, 2016</lastchanged_date>
  <firstreceived_date>December 6, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</investigator_affiliation>
    <investigator_full_name>ALDO TORRE DELGADILLO</investigator_full_name>
    <investigator_title>Investigador Oficial</investigator_title>
  </responsible_party>
  <keyword>Liver Cirrhosis,Infection, Impedance, Body Composition</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
